Recombinant Saimiri sciureus Cytochrome c oxidase subunit 6C (COX6C)

Shipped with Ice Packs
In Stock

Description

Molecular Characterization of Recombinant Saimiri sciureus COX6C

COX6C is a nuclear-encoded subunit of cytochrome c oxidase (Complex IV), critical for electron transport chain function. The recombinant version from Saimiri sciureus retains full-length structural integrity (75 amino acids) with an N-terminal 10xHis-tag for purification and detection.

ParameterSpecification
AccessionUniprot: Q7YRJ9
Amino Acid SequenceASEVLAKPQMRGLLARRLRIHMVGAFLISLGVAALYKFGVAEPRKKAYADFYKNYSPEKD FEEMKKAGVFRSIK
Molecular Weight~33.99 kDa (estimated based on human homolog)
Expression SystemE. coli
TagN-terminal 10xHis-tag
Protein LengthFull-length (residues 2–75)

Production and Purification

The protein is synthesized via bacterial expression systems, optimized for high yield and solubility. Critical parameters include:

AspectDetail
Host OrganismE. coli
Expression RegionMature protein (residues 2–75)
Storage BufferTris-based buffer with 50% glycerol (pH 8.0)
Purity>90% (SDS-PAGE verified)
StabilityStable at -20°C or -80°C; repeated freeze-thaw cycles discouraged

Research Applications

The recombinant protein serves as a tool for studying mitochondrial function, evolutionary conservation, and disease models.

ApplicationMethodPurpose
ELISAAntigen-coated plates with specific antibodiesQuantitative analysis of COX6C expression levels
Western BlotSDS-PAGE separation, His-tag detectionConfirmation of protein identity and purity
Antibody ProductionImmunization of animals with purified COX6CGeneration of species-specific antibodies for primate studies
Protein Interaction StudiesCo-immunoprecipitation or pull-down assaysMapping interactions with other Complex IV subunits (e.g., COX1, COX2)

Comparative Analysis with Human COX6C

While Saimiri sciureus COX6C shares structural homology with human COX6C (e.g., similar His-tag placement), sequence divergence highlights evolutionary adaptation:

FeatureSaimiri sciureus COX6C Human COX6C
Sequence Identity~77% with human (inferenced)100% (human-specific)
Tag ConfigurationN-terminal His-tagGST-tag or no tag (varies)
Expression SystemE. coliWheat germ or mammalian cells

Research Gaps and Future Directions

Current data on Saimiri sciureus COX6C remain limited to production and structural parameters. Future studies could explore:

  1. Functional roles in primate mitochondrial disorders.

  2. Comparative analysis of COX6C regulatory mechanisms across primates.

  3. Utility in vaccine or therapeutic protein development targeting mitochondrial diseases.

Product Specs

Form
Lyophilized powder
Note: While we will prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard protocol uses 50% glycerol; this can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. Please specify your required tag type for preferential development.
Synonyms
COX6C; Cytochrome c oxidase subunit 6C; Cytochrome c oxidase polypeptide VIc
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
2-75
Protein Length
Full Length of Mature Protein
Species
Saimiri sciureus (Common squirrel monkey)
Target Names
Target Protein Sequence
ASEVLAKPQMRGLLARRLRIHMVGAFLISLGVAALYKFGVAEPRKKAYADFYKNYSPEKD FEEMKKAGVFRSIK
Uniprot No.

Target Background

Function

Recombinant Saimiri sciureus Cytochrome c oxidase subunit 6C (COX6C) is a component of cytochrome c oxidase (complex IV, CIV), the terminal enzyme in the mitochondrial electron transport chain. This chain, encompassing succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (complex III, CIII), and CIV, facilitates electron transfer from NADH and succinate to molecular oxygen. This process generates an electrochemical gradient across the inner mitochondrial membrane, driving ATP synthesis. COX6C plays a crucial role in CIV's catalytic function, reducing oxygen to water. Electrons from reduced cytochrome c in the intermembrane space are transferred through the copper A center (CuA) of subunit 2 and heme A of subunit 1 to the binuclear center (BNC) in subunit 1. This BNC, composed of heme A3 and copper B (CuB), reduces molecular oxygen to two water molecules, utilizing four electrons from cytochrome c and four protons from the mitochondrial matrix.

Protein Families
Cytochrome c oxidase subunit 6c family
Subcellular Location
Mitochondrion inner membrane; Single-pass membrane protein.

Q&A

What is the basic structure and function of COX6C in Saimiri sciureus?

COX6C is a critical component of cytochrome c oxidase (Complex IV), the terminal enzyme in the mitochondrial electron transport chain that drives oxidative phosphorylation. In Saimiri sciureus (squirrel monkey), as in other mammals, this subunit contributes to the structural integrity and functional efficiency of the complex. COX6C belongs to the cytochrome c oxidase subunit 6c family, with a molecular mass of approximately 8.8 kDa . The protein participates in the electron transfer process that catalyzes the reduction of oxygen to water, which creates an electrochemical gradient across the inner mitochondrial membrane to drive ATP synthesis .

How does Saimiri sciureus COX6C compare structurally to human COX6C?

While there is high conservation among mammalian COX6C proteins, species-specific variations exist that may affect protein-protein interactions within the complex. Comparative analysis between human and Saimiri sciureus COX6C typically reveals:

FeatureHuman COX6CS. sciureus COX6CSignificance
Amino acid identityReference>90% estimatedHigh functional conservation
Post-translational modificationsWell-characterizedSimilar patterns expectedImportant for regulation
3D structureDeterminedPredicted to be similarCritical for complex assembly

Researchers should note that these minor variations might influence antibody recognition, protein-protein interactions, and potentially the kinetic properties of the assembled cytochrome c oxidase complex.

What role does COX6C play in mitochondrial respiration and cellular metabolism?

COX6C is integral to mitochondrial respiration as part of cytochrome c oxidase. The respiratory chain contains three multisubunit complexes (including complex IV containing COX6C) that cooperate to transfer electrons from NADH and succinate to molecular oxygen . Specifically, electrons from reduced cytochrome c in the intermembrane space are transferred via copper centers and heme groups to the binuclear center where oxygen is reduced to water .

Research indicates that COX6C function impacts:

Recent studies on COX6C knockdown have demonstrated significant impairment of oxidative phosphorylation, with decreased oxygen consumption rate in basal respiration, maximal respiration, and ATP turnover .

What expression systems are most effective for producing recombinant Saimiri sciureus COX6C?

Based on similar cytochrome c oxidase subunit expression studies, the most effective systems for producing recombinant COX6C include:

E. coli expression system:
Bacterial expression using vectors such as pET-32a with IPTG induction in E. coli strains like Transetta (DE3) has proven effective for other cytochrome c oxidase subunits . For optimal expression of Saimiri sciureus COX6C:

  • Clone the full-length cDNA into an expression vector with an appropriate tag (His-tag recommended for purification)

  • Transform into an E. coli expression strain optimized for membrane and mitochondrial proteins

  • Induce with IPTG at concentrations between 0.1-1.0 mM

  • Incubate at lower temperatures (16-25°C) to enhance proper folding

  • Include protease inhibitors during cell lysis to prevent degradation

Alternative expression systems include yeast (particularly P. pastoris) and mammalian cell lines, which may provide better post-translational modifications but at higher cost and complexity.

What purification strategies yield the highest purity and activity for recombinant COX6C?

Optimal purification of recombinant Saimiri sciureus COX6C typically involves:

  • Initial purification: Affinity chromatography using Ni²⁺-NTA agarose for His-tagged proteins

  • Secondary purification: Ion exchange chromatography to remove remaining contaminants

  • Final polishing: Size exclusion chromatography to separate monomeric protein from aggregates

Key considerations for maintaining activity:

  • Include mild detergents (0.1-0.5% n-dodecyl β-D-maltoside) throughout purification

  • Add stabilizing agents (10% glycerol, 1 mM DTT) to all buffers

  • Maintain pH between 7.0-8.0 and keep samples at 4°C

  • Avoid freeze-thaw cycles and store aliquots at -80°C

Typical yield from bacterial expression systems ranges from 1-5 mg/L of culture, with purity >95% achievable after complete purification.

How can researchers verify the proper folding and functionality of recombinant Saimiri sciureus COX6C?

Multiple complementary methods should be employed to verify proper folding and functionality:

Structural integrity assessment:

  • Circular dichroism (CD) spectroscopy to analyze secondary structure

  • Thermal shift assays to determine protein stability

  • Limited proteolysis to assess compact folding

Functional verification:

  • Cytochrome c oxidation assay to measure enzymatic activity, similar to methods used for other COX subunits

  • Binding assays with other complex IV subunits

  • Reconstitution experiments with isolated mitochondrial membranes

UV-spectrophotometer and infrared spectrometer analysis can be utilized to monitor the catalytic oxidation of cytochrome c, as demonstrated with other cytochrome c oxidase subunits . Additionally, researchers should verify that the recombinant protein can incorporate properly into mitochondrial complexes using blue native PAGE or sucrose gradient ultracentrifugation.

How can recombinant Saimiri sciureus COX6C be used to study mitochondrial dysfunction in disease models?

Recombinant Saimiri sciureus COX6C serves as a valuable tool for investigating mitochondrial dysfunction in various disease models:

Experimental approaches:

  • Complementation studies: Introduce wild-type or mutant recombinant COX6C into COX6C-depleted cells to assess rescue of phenotypes

  • Mitochondrial dynamics: Examine changes in mitochondrial fusion and fission using fluorescently tagged mitochondria and recombinant COX6C variants

  • Respiration analysis: Measure oxygen consumption rates with and without recombinant COX6C to assess its direct impact on respiratory function

  • ROS generation: Quantify reactive oxygen species production using fluorescent probes in cells with manipulated COX6C levels

Research findings demonstrate that COX6C knockdown results in mitochondrial fragmentation, with mitochondrial length decreasing significantly from normal levels . Electron microscopy can reveal structural changes in mitochondria, while measuring expression of mitochondrial fusion proteins such as mfn1 provides molecular insights into fusion defects .

What protein-protein interactions does COX6C form within the cytochrome c oxidase complex and how can these be studied?

COX6C forms critical interactions with other subunits of the cytochrome c oxidase complex that can be studied using recombinant proteins:

Key interactions and investigation methods:

Interaction PartnerMethod of StudyExpected Outcome
Core COX subunits (I, II, III)Co-immunoprecipitationDirect binding partners
Assembly factorsPull-down assaysTemporal assembly sequence
Cardiolipin and other lipidsLipid binding assaysStabilization requirements
Cytochrome cSurface plasmon resonanceBinding kinetics and affinity

Advanced techniques for interaction mapping:

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map interaction surfaces

  • Chemical cross-linking followed by mass spectrometry to identify proximity relationships

  • Fluorescence resonance energy transfer (FRET) to measure dynamic interactions in living cells

  • Cryo-electron microscopy of reconstituted complexes to visualize structural arrangements

Understanding these interactions provides insights into the assembly, stability, and functional regulation of the cytochrome c oxidase complex.

How does post-translational modification of COX6C affect its function in oxidative phosphorylation?

Post-translational modifications (PTMs) of COX6C can significantly alter its function within the oxidative phosphorylation system:

Common PTMs and their functional impacts:

ModificationEnzyme ResponsibleFunctional Impact
PhosphorylationVarious kinasesAlters complex assembly and activity
AcetylationAcetyltransferasesModulates protein stability
UbiquitinationE3 ligasesRegulates protein turnover
OxidationROS exposureImpairs function during oxidative stress

To study these modifications:

  • Use mass spectrometry to identify and quantify PTMs on recombinant and native COX6C

  • Create site-specific mutants that mimic or prevent specific modifications

  • Perform functional assays (oxygen consumption, ATP production) with modified proteins

  • Analyze the impact of cellular stressors on COX6C modification patterns

Research indicates that altered post-translational modifications of COX subunits may contribute to mitochondrial dysfunction observed in cancer and neurodegenerative diseases.

What are common challenges in expressing recombinant Saimiri sciureus COX6C and how can they be addressed?

Challenge 1: Poor solubility

  • Solution: Express as a fusion protein with solubility-enhancing tags (MBP, SUMO, or Thioredoxin)

  • Alternative: Include mild detergents (0.1% DDM or CHAPS) during extraction

  • Verification: Test multiple detergents at various concentrations to optimize solubilization

Challenge 2: Inclusion body formation

  • Solution: Lower induction temperature (16°C) and IPTG concentration (0.1 mM)

  • Alternative: Develop refolding protocols using gradual dialysis against decreasing urea or guanidine-HCl

  • Verification: Monitor protein folding using tryptophan fluorescence during refolding

Challenge 3: Proteolytic degradation

  • Solution: Add protease inhibitor cocktail during all purification steps

  • Alternative: Express in protease-deficient bacterial strains

  • Verification: Perform Western blot analysis with anti-tag antibodies to detect degradation products

Challenge 4: Low expression yield

  • Solution: Optimize codon usage for the expression host

  • Alternative: Try different expression vectors with stronger or inducible promoters

  • Verification: Conduct time-course expression analysis to determine optimal harvest time

How can researchers troubleshoot loss of activity in recombinant COX6C during purification and storage?

Activity loss during purification and storage can significantly impact research outcomes. Systematic troubleshooting should include:

During purification:

  • Monitor activity at each purification step using cytochrome c oxidation assays

  • Include stabilizing agents (10% glycerol, 1 mM DTT, 0.1% detergent) in all buffers

  • Keep samples on ice and minimize purification time

  • Avoid harsh elution conditions; use imidazole gradient elution for His-tagged proteins

During storage:

  • Store at -80°C in small aliquots to prevent freeze-thaw cycles

  • Include cryoprotectants (15-20% glycerol or sucrose)

  • Add reducing agents (1-5 mM DTT or β-mercaptoethanol) to prevent oxidation

  • Prepare protein at concentrations above 0.5 mg/mL to prevent adsorption to tubes

Activity recovery strategies:

  • Dialyze against fresh buffer containing cofactors

  • Remove potential inhibitors through size exclusion chromatography

  • Add lipids or detergent micelles to stabilize hydrophobic regions

  • Perform mild refolding by dialysis against decreasing concentrations of denaturing agents

What controls are essential when studying the impact of COX6C variants on mitochondrial function?

Essential experimental controls:

Control TypePurposeImplementation
Wild-type recombinant COX6CBaseline functionExpress and purify under identical conditions
Catalytically inactive mutantNegative controlIntroduce mutations in critical residues
Empty vectorBackground activityTransfect cells with expression vector lacking COX6C
Isogenic cell linesGenetic background controlUse CRISPR to generate COX6C knockout before complementation
Restoration of phenotypeCausality verificationRescue experiments with wild-type protein

Critical measurements:

  • Oxygen consumption rate (OCR) in basal and maximal respiration conditions

  • ATP synthesis rate in isolated mitochondria

  • Mitochondrial membrane potential using potentiometric dyes

  • ROS production with specific fluorescent probes

  • Mitochondrial morphology using fluorescence microscopy and electron microscopy

Recent research has demonstrated that COX6C knockdown significantly decreases OCR in basal respiration, maximal respiration, and ATP turnover while increasing ROS production . These parameters should be measured when testing COX6C variants.

What techniques can be used to study the incorporation of recombinant COX6C into the cytochrome c oxidase complex?

Studying the incorporation of recombinant COX6C into cytochrome c oxidase requires sophisticated analytical approaches:

In vitro reconstitution:

  • Isolate native cytochrome c oxidase complex lacking COX6C

  • Incubate with recombinant COX6C under physiological conditions

  • Analyze complex assembly using blue native polyacrylamide gel electrophoresis (BN-PAGE)

  • Perform activity assays before and after reconstitution to assess functional recovery

Cellular incorporation:

  • Express tagged recombinant COX6C in COX6C-depleted cells

  • Isolate mitochondria and solubilize with mild detergents

  • Perform immunoprecipitation with antibodies against other complex IV subunits

  • Analyze co-precipitated proteins by Western blotting and mass spectrometry

Real-time monitoring:

  • Generate fluorescently tagged COX6C variants

  • Use live-cell imaging to track incorporation into mitochondria

  • Perform fluorescence recovery after photobleaching (FRAP) to assess dynamics

  • Correlate incorporation with restoration of mitochondrial function

How can researchers differentiate between direct and indirect effects of COX6C manipulation on mitochondrial function?

Distinguishing direct from indirect effects requires carefully designed experiments:

Immediate vs. delayed effects:

  • Use inducible expression or degradation systems for temporal control

  • Monitor mitochondrial parameters at multiple time points after COX6C manipulation

  • Early changes (minutes to hours) suggest direct effects, while later changes (days) may be adaptive responses

Specific rescue experiments:

  • Identify potential downstream effectors through proteomics and transcriptomics

  • Manipulate these effectors independently of COX6C

  • Determine if specific phenotypes can be rescued without restoring COX6C function

Molecular pathway analysis:

  • Use specific inhibitors of signaling pathways activated by mitochondrial dysfunction

  • Measure activation of AMPK and other energy-sensing pathways

  • Correlate pathway activation with specific mitochondrial defects

Research has shown that COX6C knockdown activates the AMPK pathway through ROS accumulation, leading to abnormalities in spindle formation and chromosome segregation . Using AMPK inhibitors can help differentiate between direct effects on oxidative phosphorylation and indirect effects through signaling pathways.

What computational approaches can predict the functional impact of COX6C mutations or modifications?

Computational methods offer powerful approaches for predicting how mutations or modifications might affect COX6C function:

Structural prediction and analysis:

  • Homology modeling based on related structures

  • Molecular dynamics simulations to assess structural stability

  • Docking studies with interaction partners, similar to those performed with allyl isothiocyanate (AITC) and cytochrome c oxidase subunits

  • Identification of critical binding residues and potential hydrogen bonds

Evolutionary analysis:

  • Multiple sequence alignment across species to identify conserved residues

  • Calculation of evolutionary rate to identify functional constraints

  • Coevolution analysis to identify residues that evolve together, suggesting functional linkage

  • Prediction of potentially damaging versus neutral variants

Systems biology approaches:

  • Network analysis to predict effects on related mitochondrial pathways

  • Flux balance analysis to model impacts on cellular metabolism

  • Integration of transcriptomic, proteomic, and metabolomic data

  • Machine learning models trained on known mitochondrial disease mutations

These computational predictions should always be validated experimentally, but they provide valuable guidance for experimental design and interpretation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.